Literature DB >> 12368811

Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase.

Anton Glieder1, Edgardo T Farinas, Frances H Arnold.   

Abstract

We have converted cytochrome P450 BM-3 from Bacillus megaterium (P450 BM-3), a medium-chain (C12-C18) fatty acid monooxygenase, into a highly efficient catalyst for the conversion of alkanes to alcohols. The evolved P450 BM-3 exhibits higher turnover rates than any reported biocatalyst for the selective oxidation of hydrocarbons of small to medium chain length (C3-C8). Unlike naturally occurring alkane hydroxylases, the best known of which are the large complexes of methane monooxygenase (MMO) and membrane-associated non-heme iron alkane monooxygenase (AlkB), the evolved enzyme is monomeric, soluble, and requires no additional proteins for catalysis. The evolved alkane hydroxylase was found to be even more active on fatty acids than wild-type BM-3, which was already one of the most efficient fatty acid monooxgenases known. A broad range of substrates including the gaseous alkane propane induces the low to high spin shift that activates the enzyme. This catalyst for alkane hydroxylation at room temperature opens new opportunities for clean, selective hydrocarbon activation for chemical synthesis and bioremediation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368811     DOI: 10.1038/nbt744

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  63 in total

Review 1.  The bioinorganic chemistry of iron in oxygenases and supramolecular assemblies.

Authors:  John T Groves
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

2.  Directed evolution methods for overcoming trade-offs between protein activity and stability.

Authors:  Samuel D Stimple; Matthew D Smith; Peter M Tessier
Journal:  AIChE J       Date:  2019-10-09       Impact factor: 3.993

3.  Tuning genetic control through promoter engineering.

Authors:  Hal Alper; Curt Fischer; Elke Nevoigt; Gregory Stephanopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-25       Impact factor: 11.205

Review 4.  Laboratory-directed protein evolution.

Authors:  Ling Yuan; Itzhak Kurek; James English; Robert Keenan
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

5.  Identifying functionally important mutations from phenotypically diverse sequence data.

Authors:  Kyle Jensen; Hal Alper; Curt Fischer; Gregory Stephanopoulos
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

6.  Re-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamide.

Authors:  Ling Sun; Chong S Chen; David J Waxman; Hong Liu; James R Halpert; Santosh Kumar
Journal:  Arch Biochem Biophys       Date:  2007-01-08       Impact factor: 4.013

7.  Evolutionary history of a specialized p450 propane monooxygenase.

Authors:  Rudi Fasan; Yergalem T Meharenna; Christopher D Snow; Thomas L Poulos; Frances H Arnold
Journal:  J Mol Biol       Date:  2008-06-28       Impact factor: 5.469

8.  Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.

Authors:  Joshua N Kolev; Kristen M O'Dwyer; Craig T Jordan; Rudi Fasan
Journal:  ACS Chem Biol       Date:  2013-11-08       Impact factor: 5.100

9.  A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds.

Authors:  Andrew M Sawayama; Michael M Y Chen; Palaniappan Kulanthaivel; Ming-Shang Kuo; Horst Hemmerle; Frances H Arnold
Journal:  Chemistry       Date:  2009-11-02       Impact factor: 5.236

10.  Proline availability regulates proline-4-hydroxylase synthesis and substrate uptake in proline-hydroxylating recombinant Escherichia coli.

Authors:  Francesco Falcioni; Lars M Blank; Oliver Frick; Andreas Karau; Bruno Bühler; Andreas Schmid
Journal:  Appl Environ Microbiol       Date:  2013-03-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.